Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety database

Jennifer R. Brown; Paolo Ghia; Wojciech Jurczak; Brad S. Kahl; Nicole Lamanna; Tadeusz Robak; Mazyar Shadman; Constantine S. Tam; Lugui Qiu; Jason Paik; Tommi Salmi; Liping Wang; Jun Zhang; Meng Zhang; Aileen Cohen; Han Ma; Alessandra Tedeschi

doi:10.3324/haematol.2023.283846

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Articles

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety database

Jennifer R. Brown
Paolo Ghia
Wojciech Jurczak
Brad S. Kahl
Nicole Lamanna
Tadeusz Robak
Mazyar Shadman
Constantine S. Tam
Lugui Qiu
Jason Paik
Tommi Salmi
Liping Wang
Jun Zhang
Meng Zhang
Aileen Cohen
Han Ma
Alessandra Tedeschi

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan

Maria Skłodowska-Curie National Research Institute of Oncology, Kraków

Siteman Cancer Center, Washington University School of Medicine, St Louis, MO

Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

Medical University of Łódź, Łódź

Fred Hutchinson Cancer Research Center, Seattle, WA

Alfred Hospital and Monash University, Melbourne, VIC

State Key Laboratory of Experimental Hematology, National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin

BeiGene USA, Inc, San Mateo, CA

BeiGene International GmbH, Basel

BeiGene (Shanghai) Co, Ltd, Shanghai

BeiGene USA, Inc, San Mateo, CA

ASST Grande Ospedale Metropolitano Niguarda, Milan

Haematologica Early view Feb 29, 2024 https://doi.org/10.3324/haematol.2023.283846

Figures & Tables

Article Information

Early view : Articles

DOI

https://doi.org/10.3324/haematol.2023.283846

Pubmed

38426293

Published

2024-02-29

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

1416

PDF Downloads

521

Statistics from Altmetric.com

No Data

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety database

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More